Skip to content

What is ALS?
Managing ALS
Get Support
Take Action
Research
Advocacy
About Us

Search
FAQ
Resources
Stories
News

Donate

FAQ
Resources
Stories
News

Donate

What is ALS?
- - - Learn About ALS
    - Overview
    - About ALS
    - Symptoms
    - Diagnosis
    - Treatments
- - - What if I might have ALS?
    - How to get diagnosed
    - Find an ALS Clinic near you
    - View ALS FAQ
    - View ALS Resources
Managing ALS
- - - How to manage ALS
    - Living with ALS
    - ALS Canada Gene Hub
    - ALS Clinics
- - - Additional Information
    - Canadian Best Practice Recommendations
    - Available resources
Get Support
- - - Additional Information
    - Information for Healthcare Professionals
    - Get guidance on living with ALS
Take Action
- - - Other ways to help
    - Participate in Clinical Trials
    - Participate in ALS Advocacy
    - Become a Corporate Partner
Research
- - - Additional Information
    - Information for Researchers
    - View Research FAQ
    - View Research News
Advocacy
- - - Additional Information
    - Download our Advocacy Toolkit
    - View Advocacy News
About Us
- - - Learn about ALS Canada
    - Who We Are
      - Annual Reports & Financials
      - Strategic Plan
    - Our Impact
      - Stories
      - Impact of Donations
    - Our Team
    - Our Partners
    - Contact Us
- - - Additional Information
    - View our Financials
    - Check out our Careers
    - View ALS Canada FAQ
    - View ALS Canada News

Link copied!

Funded Projects
Novel therapies for ALS

Funded Projects

Novel therapies for ALS

$207,657 awarded to Dr. John Roder at University of Toronto.

Project Details

Funding Amount

$207,657

Awardee

John Roder

Host Institution

University of Toronto

Province |Ontario

Funding Program

Neuromuscular Research Partnership (NRP)

Year Awarded |2000

Funded By

CIHR
Muscular Dystrophy Canada

Explore more funded projects.

Mapping Alternative Polyadenylation and Splicing in ALS via Single-Nucleus Long-Read Transcriptomics

Read news article

Development of a lead importin-β1 modulator for therapeutic rescue of TDP-43 pathology in ALS

Read news article

Feasibility RCT of a digital tool for management of bulbar disease in ALS

Read news article

Our Financials

For every dollar we raise, we invest less than 30 cents in fundraising efforts — including events, direct mail, and major gifts — ensuring that the majority of our revenue directly supports our mission.

See the Impact of Donations

Have questions? We’re here to help.

Contact us
View our FAQ

The Standards Program Trustmark is a mark of Imagine Canada used under licence by the ALS Society of Canada. Registration No. 10670-8977-RR0002.

2026 Amyotrophic Lateral Sclerosis Society of Canada

Careers
Sitemap
Accessibility
Privacy Policy
Contact Us

Search

What are you looking for?

Popular searches:

What is ALS? Donate Equipment in Ontario Symptoms About ALS Contact Us Get Support

We use cookies and other technologies to understand how you use our site and to improve your experience and provide you with valuable content. By continuing on this website, you consent to the use of these cookies. For more information and to opt-out of cookies, visit the cookie section of our privacy policy.